The HCA Healthcare Sarah Cannon Cancer Network is a leading provider of cancer care services, treating 130,000 new cancer patients annually across 20 states and the UK. They offer a focus on collaboration, clinical excellence, and advanced research.
As the largest provider of cellular therapy in the US, they conduct 1,600 annual transplants and cellular therapies, along with providing 900 daily radiation treatments through their radiation oncology centers. The network enrolls 4,500 patients in clinical trials and conducts 750 first-in-human studies each year, dedicated to transforming cancer care with a patient-centered approach.
Generated from the website